Wstęp do publikacji na 100 Lecie Odzyskania Niepodległości

Zaproszenie do udziału w Projekcie

Profesor Rafael Fonseca
Mayo Clinic w USA

Joshua Richter,

MD Assistant Professor of Medicine Tisch Cancer Institute

LAURENT GARDERET

INSERM, UMR_S 938, Centre de Recherche Saint-Antoine-Team Proliferation and Differentiation of Stem Cells, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Service d’Hématologie, Sorbonne Université, Paris, France

David H. Vesole

MD PhD John Theurer Cancer Center,
Hackensack University Medical Center

Professor Torben PLESNER
Vejle Hospital and University of Southern Denmark, Vejle, Denmark.

Enrique M. Ocio MD, PhD

Head of the Hematology Department
University Hospital “Marqués de Valdecilla”
University of Cantabria

Prof.MUDr. Ivan Špička, CSc.

1st Department of Medicine – Department of Hematology First Faculty of Medicine Charles University and General Hospital in Prague

Dr EDVAN CRUSOE

Universidade Federal da Bahia (UFBA), Hospital Universitário Professor Edgard Santos, Salvador, BA, Brazil 

Professor Michel O`Dwyer

Centre for Research in Medical Devices (CÚRAM), National University of Ireland, Galway, Ireland

ANDREW J YEE
Harvard Medical School, Boston, MA
Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA

Professor Meral BEKSAC
Department of Hematology, Ankara University School of Medicine, Ankara, Turkey

Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute
Adjunct Professor, College of Health Solutions, Arizona State University

Professor Robert A. KYLE, MD
Division of Hematology, Mayo Clinic, Rochester, MN, USA

Natalie S. Callander, M.D.
Professor of Medicine
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center

HERMANN EINSEL
Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Professor IRIT AVIVI
Department of Hematology, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel; Sackler Faculty of Medicine,
Tel-Aviv University, Ramat Aviv, Israel

Professor Chaim SHUSTIK
McGill University Health Centre, Montreal, QC, Canada

Professor HARTMUT GOLDSCHMIDT
Heidelberg University Hospital | Department V | Multiple Myeloma Section Im Neuenheimer Feld 410 | 69120 Heidelberg

David Siegel, MD, PhD. Chief, Division of Myeloma
Founding Director, Institute for Multiple Myeloma
Hackensack Meridian Health, Center for Discovery & Innovation

Dr NATALIA TOVAR
Unitat de noves terapies
Escala 4 3º planta
Hospital Clinic Barcelona

Profesor Marek Hus
Klinika Hematoonkologii i Transplantacji Szpiku Lublin

Professor Helena Zakharova,

Chair of Department of Nephrology, Moscow City Hospital n.a. S. P. Botkin

Alessandro Gozzetii University of Siena,

Department of Hematology, Siena, Italy

XU FANG

Department of Hematology, Mianyang Central Hospital, Mianyang 621000, Sichuan, People’s Republic of China

Rafat Abonour, M.D.

Harry and Edith Gladstein Professor of Cancer Research
Professor of Medicine, Pathology and Laboratory Medicine
Director, Multiple Myeloma,  Waldenstrom’s Disease and Amyloidosis Program

DEEPU MADDURI,

MD Icahn School of Medicine at Mount Sinai Tisch Cancer Institute Ringgold Standard Institution – Hematology/Oncology, New York, USA

Professor YE YANG

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,
Nanjing, China

Dr GABOR MIKALA

Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, National Institute of Hematology and Infectology, Budapest, Hungary

Professor Graham Jackson
NCCC Freeman Hospital

Professor Jonathan L. KAUFMAN

Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 

Elisabet E. Manasanch, M.D., M.H.Sc.
Associate Professor
Clinical Director Myeloma Tissue Bank
Department of Lymphoma/Myeloma
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center

Gösta Gahrton M.D.,
Emeritus Professor of Medicine, Karolinska Institutet, Department of Medicine, Huddinge, Stockholm, Sweden

Professor Ruben NIESVIZKY, MD
Center for Myeloma, New York Presbyterian Hospital-Weill
Cornell Medical Center, New York, NY USA

Professor Kenneth C. Anderson
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Daniel CORIU
Hematology and Bone Marrow Transplant Department, Fundeni Clinical Institute, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Prof. Jesús San-Miguel
Director of Clinical & Translational Medicine
University of Navarra. Spain

Vaishali Sanchorawala, MD
Professor of Medicine
Director, Autologous Stem Cell Transplant Program
Director, Amyloidosis Center
Boston Medical Center and Boston University School of Medicine

Prof. Gordon Cook
Professor of Haematology & Myeloma Studies
Clinical Director (Haematology), Clinical Trials
Research Unit
Clinical Director NIHR (Leeds) IVD Cooperative
Level 03, Leeds Cancer Centre
St James’s University Hospital

Julio Davila
Department of Hematology
Complejo Asistencial de Avila, Spain

Professor Chaim SHUSTIK
McGill University Health Centre, Montréal, QC, Canada

Professor Jean Luc HAROUSSEAU
Institut de Cancerologie de l’Ouest, Centre René Gauducheau, Nantes-St Herblain, France

Morie A Gertz, M.D., M.A.C.P.

Consultant | Division of Hematology |Roland Seidler Jr. Professor Department of Medicine | College of Medicine |Mayo Distinguished Clinician|

Professor RAVI VIJ

Washington University School of Medicine, St. Louis, MS, USA.

Siegfried Janz, MD, DSc

William G. Schuett, Jr., Multiple Myeloma Endowed Chair
Professor of Medicine | Director of Myeloma Biology Program
Division of Hematology & Oncology | Department of Medicine | Medical College of Wisconsin Milwaukee

Univ.-Prof. Dr. Nóra Szentmáry

Dr. Rolf M. Schwiete Zentrum
für Limbusstammzellforschung und kongenitale Aniridie
Universität des Saarlandes

Luciano J. Costa, MD, PhD
Associate Professor of Medicine
Medical Director OCCC clinical trials office
Chair Hematologic Malignancies Working Group
UAB | The University of Alabama at Birmingham

Jorge J. Castillo, MD

Clinical Director, Bing Center for Waldenstrom Macroglobulinemia
Division of Hematological Malignancies, Dana-Farber Cancer Institute
Associate Professor, Harvard Medical School

Guillermo J.RUIZ-ARGUELLES MD, FRCP(GLASG), MACP, DSC (HC) FRCP

DIRECTOR GENERAL, CENTRO DE HEMATOLOGIA Y MEDICINA INTERNA
DIRECTOR OF RESEARCH, LABORATORIOS RUIZ

Navneet Majhail, MD, MS   
Director, Blood and Marrow Transplant Program
Vice Chair, Department of Hematology-Oncology

Pashna N. Munshi, MD
MedStar Georgetown University Hospital, Washington, DC, USA

Ajay K. Nooka, MD
School of Medicine, Emory University, Atlanta, GA, USA

Professor H Denis Alexander DPhil FRCPath
N Ireland Centre for Stratified Medicine
Ulster University, C-TRIC Building,
Altnagelvin Area Hospital

Jesús G. Berdeja, M.D.
Director of Multiple Myeloma Research
Sarah Cannon Research Institute

Suzanne Lentzsch, M.D., Ph.D.
Professor of Medicine at Columbia University
Director, Multiple Myeloma and Amyloidosis Service

ANDERS WAAGE
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

TOMAS PIKA
DEPARTMENT OF HEMATOONCOLOGY, UNIVERSITY HOSPITAL OLOMOUC,
OLOMOUC, CZECH REPUBLIC

Professor Parameswaran HARI
Medical College of Wisconsin, Milwaukee, Wisconsin, USA

James CS Chim
SH Ho Professor of Hematology & Oncology
Division of Haematology and Medical Oncology, Queen Mary
Hospital, Hong Kong, China

Dr JAKUB RADOCHA
4th Department of Internal Medicine – Hematology
University Hospital Hradec Kralove, Charles University
Hradec Kralove;  Czech Republic

Prof. Ashutosh Wechalekar
Professor of Medicine and Haematology

PODZIĘKOWANIA

Ksiądz Arcybiskup Wojciech Polak

Prymas Polski

ks. prof. dr hab. Mirosław Kalinowski
Rektor Katolickiego Uniwersytetu Lubelskiego Jana Pawła II

Prof. Dr Hab. N. Med. Zbigniew Gaciong
Rektor Warszawskiego Uniwersytetu Medycznego

Arcybiskup
Marek Jędraszewski
Metropolita Krakowski

Arkady Rzegocki
Ambasador Rzeczypospolitej Polskiej w Zjednoczonym Królestwie Wielkiej Brytanii i Irlandii Północnej

Adam Bodnar
Rzecznik Praw Obywatelskich

Arcybiskup
Adam Szal
Metropolita Przemyski

Marek Goliszewski, Prezes PAU

Profesor Jan Ostrowski, Prezes PAU

MIESIĘCZNIK “KRAKÓW” – Recenzja Książki “Wszystkie Twarze Szpiczaka”

Profesor Rafael Fonseca z Mayo Clinic w USA

Joshua Richter,

MD Assistant Professor of Medicine Tisch Cancer Institute

LAURENT GARDERET

INSERM, UMR_S 938, Centre de Recherche Saint-Antoine-Team Proliferation and Differentiation of Stem Cells, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Service d’Hématologie, Sorbonne Université, Paris, France

David H. Vesole

MD PhD John Theurer Cancer Center,
Hackensack University Medical Center

Professor Torben PLESNER
Vejle Hospital and University of Southern Denmark, Vejle, Denmark.

Enrique M. Ocio MD, PhD

Head of the Hematology Department
University Hospital “Marqués de Valdecilla”
University of Cantabria

Prof.MUDr. Ivan Špička, CSc.

1st Department of Medicine – Department of Hematology First Faculty of Medicine Charles University and General Hospital in Prague

Prof. Dr. med. H. Goldschmidt
Multiple Myeloma Section
Heidelberg University Hospital

Professor Helena Zakharova,

Chair of Department of Nephrology, Moscow City Hospital n.a. S. P. Botkin

Alessandro Gozzetii University of Siena,

Department of Hematology, Siena, Italy

XU FANG

Department of Hematology, Mianyang Central Hospital, Mianyang 621000, Sichuan, People’s Republic of China

Rafat Abonour, M.D.

Harry and Edith Gladstein Professor of Cancer Research
Professor of Medicine, Pathology and Laboratory Medicine
Director, Multiple Myeloma,  Waldenstrom’s Disease and Amyloidosis Program

DEEPU MADDURI,

MD Icahn School of Medicine at Mount Sinai Tisch Cancer Institute Ringgold Standard Institution – Hematology/Oncology, New York, USA

Professor YE YANG

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,
Nanjing, China

Dr GABOR MIKALA

Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, National Institute of Hematology and Infectology, Budapest, Hungary

Morie A Gertz, M.D., M.A.C.P.

Consultant | Division of Hematology |Roland Seidler Jr. Professor Department of Medicine | College of Medicine |Mayo Distinguished Clinician|

Professor RAVI VIJ

Washington University School of Medicine, St. Louis, MS, USA.

Siegfried Janz, MD, DSc

William G. Schuett, Jr., Multiple Myeloma Endowed Chair
Professor of Medicine | Director of Myeloma Biology Program
Division of Hematology & Oncology | Department of Medicine | Medical College of Wisconsin Milwaukee

Univ.-Prof. Dr. Nóra Szentmáry

Dr. Rolf M. Schwiete Zentrum
für Limbusstammzellforschung und kongenitale Aniridie
Universität des Saarlandes

Luciano J. Costa, MD, PhD
Associate Professor of Medicine
Medical Director OCCC clinical trials office
Chair Hematologic Malignancies Working Group
UAB | The University of Alabama at Birmingham

Jorge J. Castillo, MD

Clinical Director, Bing Center for Waldenstrom Macroglobulinemia
Division of Hematological Malignancies, Dana-Farber Cancer Institute
Associate Professor, Harvard Medical School

Guillermo J.RUIZ-ARGUELLES MD, FRCP(GLASG), MACP, DSC (HC) FRCP

DIRECTOR GENERAL, CENTRO DE HEMATOLOGIA Y MEDICINA INTERNA
DIRECTOR OF RESEARCH, LABORATORIOS RUIZ

Opinie Profesorów

The book “All Faces of Multiple Myeloma” arrived safely.  Thank you very much for sending it.

The 100 stories will be of great interest and support to patients with myeloma.

Each story is different with no two patients being the same.  That has been my clinical experience as well over the years.  No one is exactly the same as another patient.  They all have differences.  The patient with multiple myeloma for 24 years will be inspirational for many patients.  They will realize that patients can do well with the disease.  I just wish that more of them did so.

Robert Kyle z Mayo Clinic